InvestorsHub Logo
Followers 17
Posts 343
Boards Moderated 0
Alias Born 07/01/2008

Re: clambottler post# 77148

Monday, 05/11/2020 4:42:52 PM

Monday, May 11, 2020 4:42:52 PM

Post# of 232978
THE CEO SHOULD HAVE DILUTED --- And He Did NOT
That is what makes this so worthwhile --

A. GILD shows you the FDA removed barriers to approval.
Survival benefit to just getting out of your hospital bed 5 days earlier gets you approval

B. There is a Ton of Money to be thrown at this by the Government.
See NVAX The US Gov just gave them $ 384 MILLION


CYDY KNOWS IT -- THEY COULD HAVE DONE A SHARE SALE they could easily have sold 50 million shares at $ .75 when the price was $ 3.5 if they wanted

The CEO could have diluted and Did Not ---

The CEO SHOULD have diluted and Did Not --- Any CEO knows to Sell Shares prior to an unblinding if the price is high --- just in case of failure.

----->>>>>> that shows the extreme faith he has in the drug.


Could have diluted
Should have diluted -- No One Would have blamed him for selling
50 million more shares

Did Not Dilute --- pending additional proof from the testing.


Great Faith in the Drug
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News